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ABSTRACT 
 
 
 Bardet-Biedl Syndrome (BBS) is a pleiotropic ciliopathy characterized by a 
unique phenotype including obesity, type II diabetes, polydactyly, cognitive deficiency, 
and blindness. The high prevalence of obesity (70-90%) and diabetes (up to 48%) among 
BBS patients has drawn attention to the disease as a way to discover previously unknown 
biochemical and developmental pathways connected to the disease’s phenotypic 
manifestations. Immunofluorescence staining and perifusion showed low levels of insulin 
in pancreatic islets of BBS2 knockout mice. Glucose tolerance testing showed glucose 
intolerance, and insulin tolerance testing showed insulin resistance among BBS2 
knockout mice, indicating the potential for disregulation of glucose homeostasis as a 
result of BBS2 depletion. Primary cilia in pancreatic islets were examined because BBS 
is a ciliopathy, and a unique phenotype of atypically short cilia was observed in BBS2 
knockouts. BBS2 knockdown was accomplished in vitro and showed lower insulin levels, 
supporting the previous findings that loss of BBS2 leads to low insulin levels. The link 
between BBS and obesity led to examining the canonical wnt signaling pathway, a known 
adipogenesis repression pathway. Several canonical wnt genes were seen to be 
downregulated as a result of BBS2 knockdown. The wnt target gene Cyclin D1 is a cell 
cycle progression marker and it was also downregulated. Cell cycle analysis showed s-
phase arrest during BBS2 knockdown. Both the in vivo and in vitro experiments pointed 
to the importance of BBS2 for normal glucose homeostasis, and provided a new model 
for diabetes research. 
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BACKGROUND 
 
Primary Cilia 
Most cells in the human body contain a solitary cilium extending from the cell 
membrane into the extracellular environment. These cilia have come to be known as 
primary cilia, and they are typically immotile organelles found in almost every type of 
cell in the human body (Pedersen, et al., 2008; Wheatley, et al., 1996; Yokoyama, 2004). 
Cells grow primary cilia when they enter the G0 phase of the growth cycle, and there are 
three stages of cilia formation, as shown in Figure 1 (Pedersen, et al., 2008). The first 
stage occurs when a centriolar vesicle derived from the cell’s Golgi apparatus attaches to 
a mother centriole. The centriolar vesicle invaginates, creating a pocket for the axoneme, 
which emerges from the centriole. In the second stage, secondary centriolar vesicles join 
with the original centriolar vesicle to accommodate the growing axoneme; during this 
stage, microtubule pairs form along the axoneme. The third stage of primary cilia 
formation occurs when the centriolar vesicle fuses with the cell membrane and the 
primary cilia is able to extend out into the extracellular environment (Pedersen, et al., 
2008). 
 
Figure 1: The stages of primary cilia assembly (Pedersen, et al., 2008). 
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Primary cilia are defined by their unique 9 + 0 structure in which there are nine 
microtubule triplets arranged in a circle in the cilium. Unlike motile cilia, primary cilia 
lack the central microtubule pair necessary for cilia mobility (Wheatley, et al., 1996; 
Yokoyama, 2004). Primary cilia can vary greatly in length, but a study by Wheatley and 
Bowser on kidney epithelial cells shows that cell populations typically have cilia length 
frequency distributions reminiscent of a bell curve. Their study showed primary cilia 
tended to be around 10.5 microns in length, and their histogram has been included as 
Figure 2 (Wheatley, et al., 2000). 
 
 
Figure 2: Histogram of primary cilia lengths in a kidney cell line showing the 
approximate length distribution of wild type primary cilia (Wheatley, et al., 
2000). 
Due to their prevalence and based on the disorders in which they are disrupted, 
primary cilia are widely believed to be involved in cell signaling, left-right asymmetry 
and development, and tissue formation and homeostasis (Pedersen, et al., 2008; 
Yokoyama, 2004; Christensen, et al., 2007). The role of primary cilia as sensory 
organelles makes them important in cell signaling. In the kidneys primary cilia have been 
shown to function as mechanosensors involved in monitoring urine composition and flow 
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rate (Christensen, et al., 2007). They have also been shown to coordinate platelet-derived 
growth factor receptor-alpha (PDGFRα) mediated signaling, which is involved in cell 
survival regulation, apoptosis, proliferation, migration, and angiogenesis (Christensen, et 
al., 2007). 
A special kind of motile primary cilia has also been linked to left-right asymmetry 
during development. During development, primary cilia on node cells move to create 
nodal flow, which moves extracellular fluid from the right to the left. When nodal cilia 
were mutated so that they were either missing or immotile, left-right asymmetry didn’t 
occur and situs inversus, physiological symmetry along the midline, was observed 
(Yokoyama, 2004). Additionally, studies where primary cilia were mutated showed 
disrupted Hedgehog and Gli protein regulation, both of which are essential for left-right 
asymmetry (Christensen, et al., 2007). 
In addition to their role in development, primary cilia are also crucial for tissue 
formation and homeostasis. Primary cilia were shown to be necessary for proper 
forebrain development due to their role in proteolytic processing of the Gli3 transcription 
factor (Willaredt, et al., 2008). Then, in another study, mice with disrupted primary cilia 
showed pancreatic defects such as pancreatic duct expansion, cyst formation, and acinar 
cell apoptosis as well as renal cysts (Cano, et al., 2004). Primary cilia also play a role in 
photoreception and olfaction. For olfaction to occur, odorants must react with G Protein 
Coupled Receptors found on cilia membranes, and the presence of various olfactory 
signaling receptors in cilia indicates that cilia are crucial for odorant reception and 
signaling. Similarly, photoreception is also dependent on cilia signaling pathways. Both 
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rods and cones have primary cilia which are necessary for light reception and 
transduction (Singla, et al., 2006). 
Ciliopathies 
The wide variety of primary cilia functions and the importance of these functions 
show just how essential this organelle is. Any disruptions in primary cilia formation 
greatly affect their ability to function, as can be seen in ciliopathies. Ciliopathies are a 
group of human disorders associated with defects in cilia structure and function and 
which share several clinical phenotypes (Badano, et al., 2006). The nine phenotypes used 
to identify ciliopathies include retinitis pigmentosa, renal cystic disease, polydactyly, 
situs inversus, mental retardation and developmental delay, agenesis of the corpus 
callosum, Dandy-Walker malformation, posterior encephalocele, and hepatic disease. 
Retinitis pigmentosa occurs with the degeneration of photoreceptor cells, especially rods, 
which over time lose their ability to function (Saade, et al., 2013). Renal cystic disease 
occurs when cysts form in the kidneys (Badano, et al., 2006), and polydactyly is the 
presence of extra digits, which typically presents as extra fingers. As mentioned above, 
situs inversus occurs when left-right asymmetry is disrupted and the body is anatomically 
symmetric across the midline. Agenesis (hypoplasia) of the corpus callosum is 
underdevelopment of the band of nerve fibers that connect the left and right hemispheres 
of the brain. Dandy-Walker malformation is a syndrome in which the cerebellar vermis is 
underdeveloped, the fourth ventricle displays cystic dilation, and the posterior fossa is 
enlarged (Hamid, 2007). Posterior encephalocele occurs when the posterior lobe of the 
brain protrudes through a fissure in the skull. 
From the above list of clinical features, eleven disorders have been identified as 
being due to cilia dysfunction. These diseases are the ciliopathies, and they include 
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Bardet-Biedl Syndrome (BBS), nephronophthisis (NPHP), Senior-Løken Syndrome 
(SNLS), Alström Syndrome (ALMS), Meckel-Gruber Syndrome (MKS), Joubert 
syndrome (JBTS), oral-facial-digital Syndrome (OFD 1), Jeune asphyxiating thoracic 
dystrophy (JATD), Ellis-van Creveld Syndrome (EVC), Leber congenital amaurosis 
(LCA), and Polycystic Kidney Disease (PKD) (Baker, et al., 2009). 
Bardet-Biedl Syndrome (BBS) 
Bardet-Biedl Syndrome (BBS) is a pleiotropic, autosomal recessive ciliopathy 
(Forsythe, et al., 2013). The major and minor phenotypic characteristics used to diagnose 
BBS are listed in Table 1, and a positive BBS diagnosis is based on the presence of either 
four major characteristics or three major characteristics and two minor characteristics. It 
is also recommended that a positive BBS diagnosis or a suspected case of BBS be 
confirmed by molecular genetic testing (Forsythe, et al., 2013; Baker, et al., 2009). 
 
Table 1: The major and minor characteristics used to diagnose BBS (Forsythe, et al., 2013; Baker, et al., 2009). 
 
 
The BBS phenotype appears over the first decade of life, but there is considerable 
phenotypic variance among BBS patients (Forsythe, et al., 2013). Rod-cone dystrophy is 
highly prevalent in BBS, and most BBS patients are legally blind by the age of 20-30 
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years old. First the rods degenerate, leading to night blindness and the development of 
photophobia; after this the cones are typically affected, and both color and central vision 
are lost. Post-axial polydactyly is also highly prevalent among BBS patients, and the in 
utero presence of extra fingers and toes is one of the earliest detectable signs of BBS. 
Although BBS patients are born with a birth weight within the normal range, by the age 
of 3 years old, 33% of BBS patients are obese and over time that statistic increases to 72-
92% of BBS patients. A high frequency of genital anomalies is seen among BBS patients, 
ranging from hypogenitalism and infertility in males to abnormal genitalia in females. 
Although BBS patients are typically infertile, they are capable of reproduction. Another 
tell-tale sign of BBS is renal anomalies, a major cause of mortality among BBS patients; 
renal complications typically involve kidney malformation, cystic tubular disease, and 
urine concentration defects. Finally, BBS patients have significant difficulties with 
learning, including developmental delay and cognitive impairments as well as behavior 
abnormalities (Forsythe, et al., 2013). 
Due to the disease’s pleiotropic nature and the lack of any targeted BBS 
treatments, BBS must be treated on a case-by-case basis (Sheffield, 2010). Patients are 
encouraged to have several annual examinations to watch for potential complications 
including hypertension, diabetes mellitus, and obesity. Patients are also recommended to 
be genetically confirmed for BBS; oral glucose tolerance tests, speech therapy, 
consultation with a cardiologist, review by a clinical psychologist, and orthodontic and 
dentist work are recommended as needed based on phenotype (Sheffield, 2010). 
Although the link between BBS and obesity and diabetes is not currently 
understood, it is widely believed that further research of BBS will reveal biochemical and 
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developmental pathways connected to the disease’s phenotypic manifestations. The study 
of BBS and other rare diseases has already led to a better understanding of biology and 
the discovery of previously unidentified disease genes such as the bbs genes (Sheffield, 
2010). 
BBS Genes 
Currently 16 BBS genes have been identified (Forsythe, et al., 2013; Mockel, et 
al., 2011). These genes, listed in Table 2, serve various functions within the cell, but they 
all relate to cilia function. Of the identified bbs proteins, seven form a complex known as 
the BBSome (BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, and BBS9), three form a BBS 
chaperone complex (BBS6, BBS10, BBS12), and the other six are involved in cilia 
function (Sheffield, 2010). 
Table 2: List of identified BBS genes (and other names) and their function (Forsythe, et al., 2013). 
Gene Locus Function 
BBS1 11q13 BBSome protein 
BBS2 16q21 BBSome protein 
BBS3 (ARL6) 3p12-p13 ADP-ribosylation factor-like small GTPase 
BBS4 15q22.3-23 BBSome protein 
BBS5 2q31 BBSome protein 
BBS6 (MKKS) 20p12 Part of BBS chaperonin complex 
BBS7 4q27 BBSome protein 
BBS8 (TTC8) 14q32.1 BBSome protein 
BBS9 (B1) 7p14 BBSome protein 
BBS10 12q21.2 Part of BBS chaperonin complex 
BBS11 (TRIM32) 9q31-q34.1 E3 ubiquitin ligase 
BBS12 4q27 Part of BBS chaperonin complex 
BBS13 (MKS1) 17q23 Centriole migration protein 
BBS14 (CEP290) 12q21.3 Basal body: RPGR interaction protein 
BBS15 (WDPCP) 2p15 Localization of septins and ciliogenesis protein 
BBS16 (SDCCAG8) 1q43 Basal body: OFD1 interaction protein 
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The BBSome 
The BBSome is a protein complex involved in the biogenesis of primary cilia. 
The BBSome is made up of BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, and BBS9, and it 
is a highly conserved complex found in all ciliated organisms (Jin, et al., 2009).  The 
BBSome has been related to intraflagellar transport (IFT) coordination and function, 
trafficking of signaling receptors to the primary cilium, IFT particle assembly at the 
ciliary base and ciliary tip, signaling interpretation of several hormones including leptin, 
ciliary membrane elongation, and regulation of dense-core vesicle secretion (Jin, et al., 
2009; Seo, et al., 2010; Sheffield, 2010; Wei, et al., 2012; Zhang, et al., 2011; Lee, et al., 
2011). 
BBS1, one of the BBS proteins that make up the BBSome, has been shown to 
interact with leptin receptors (Seo, et al., 2010). Leptin is an adipocyte hormone involved 
in body weight regulation, and its recently discovered connection to BBS1 has led to a 
working hypothesis that BBS1 and the BBSome are involved in interpreting leptin signal. 
Leptin is a hormone used to indicate to the brain whether or not an organism has enough 
stored fat or if food intake should be increased, and disrupted leptin signaling has been 
related to obesity and high body weights, as seen in BBS patients (Jin, et al., 2009; 
Friedman, 2008) and animals. It is known that BBS knockout animals raised with strict 
dietary control in metabolic cages do not become obese (Guo, et al., 2011). 
In addition to its role in leptin signaling, the BBSome regulates the movement of 
proteins and vesicles to the primary cilia, and it has been indicated as an important player 
in IFT. The main role of the BBSome in this capacity is to efficiently assemble IFT 
particles and reorganize the IFT complex at the base of the cilia and again at the ciliary 
tip to promote anterograde and retrograde transport respectively (Wei, et al., 2012). 
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Although IFT can take place in the absence of the BBSome, studies show this leads to 
lowered IFT coordination and disrupted retrograde transport (Jin, et al., 2009; Wei, et al., 
2012). A schematic drawing of the BBSome and an illustration of its role in IFT are 
shown in Figure 3. 
 
 
 
 
 
 
 
 
 
Figure 3: A schematic drawing of the BBSome complex with molecular interactions (Jin, et al., 
2009) and a model for the BBSome’s role in IFT assembly and turnaround adapted from (Wei, et 
al., 2012). 
 
BBS Chaperonin Complex 
 The BBSome is assembled by a chaperonin complex made of BBS6, BBS10, and 
BBS12. These chaperonin proteins, which are only found in vertebrates, rather than in all 
ciliated organisms, interact with chaperonin containing TCP-1 (CCT) proteins to mediate 
assembly of the BBSome by forming a multisubunit complex (Seo, et al., 2010). The 
BBS chaperonin proteins associate with BBS7 during BBSome assembly, and together 
these proteins assist with the folding of BBSome subunits and BBSome subunit assembly 
to create the BBSome complex. The three BBS proteins allow CCT proteins to interact 
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with the BBSome to perform protein folding; however, the BBS proteins don’t appear to 
actively participate in protein folding themselves (Seo, et al., 2010). 
Additional BBS Genes 
In addition to the BBSome and BBS chaperonin complex proteins, there are six 
other BBS proteins. BBS3 is also known as ADP-ribosylation factor-like small GTPase 
(ARL6). While BBS3 is predominantly involved in moving the BBSome to the cell 
membrane, it has also been shown to interact with Golgi vesicles and plasma membrane 
which later become ciliary membrane. Although the in vivo function of BBS3 is not yet 
fully understood, it has been shown to have a role in mediating Kv and KCa channels 
(Valentine, et al., 2012). Recently, tripartite-motif-containing protein 32 (TRIM32) has 
been shown to be BBS11. BBS11 is a widely expressed degradation compound that 
regulates dysbindin (Locke, et al., 2009; Chiang, et al., 2006). BBS13, also called 
Meckel-Gruber Syndrome 1 gene (MKS1) is involved in ciliogenesis, and mutations in 
BBS13 have been shown to disrupt Wnt and Shh signaling (Wheway, et al., 2012; 
Valentine, et al., 2012). The BBS14 protein is known as both CEP290 and NPHP6. 
BBS14 localizes to cilia, centrosomes, and nuclei, where it plays an important role in 
chromosome separation. Mutations in BBS14 have led to disrupted intraciliary and 
axonal transport, indicating a role for BBS14 in IFT (Frank, et al., 2008). BBS15 is 
believed to be WD repeat containing planar cell polarity effector (WDPCP), a tissue-
specific planar cell polarity effector gene which may control primary cilia formation and 
function (Mockel, et al., 2011; Dai, et al., 2013). The BBS16 protein is SDCCAG8, a part 
of photoreceptor sensory cilium proteome and human centrosomal proteome. While 
BBS16 depletion leads to kidney cysts, body axis defects, and cell polarity defects, all of 
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which are seen in ciliopathies, the precise relation between BBS16 and cilia function 
remains to be discovered (Otto, et al., 2010). 
Effect of Primary Cilia on Cell Cycle 
The cell cycle is composed of four main stages: G1, S, G2, and M (Figure-4). G1 
is the first of the two gap phases, and it allows the cell to determine whether or not 
environmental conditions are conducive to cell growth and division (Alberts, et al., 
2002). After G1 the cell transitions to the S (synthesis) phase, in which the cell replicates 
its DNA. The cell then spends a small amount of time in G2, the second gap phase, 
before it moves into M (mitosis), during which time cell division occurs. If conditions are 
unfavorable for cell division, however, the cell can enter G0, a prolonged resting phase in 
which cells can remain for an extended amount of time (Alberts, et al., 2002). 
 
Figure 4: Schematic drawing of cell cycle progression (2010). 
 
Recently it has been observed that upon entering the cell cycle, most cells 
disassemble their primary cilia; then, upon cell cycle completion, primary cilia are 
reassembled (Goto, et al., 2013; Quarmby, et al., 2005). Although it is not currently 
known whether or not ciliogenesis and progression through the cell cycle are mutually 
exclusive events, it has been shown to be a possibility (Goto, et al., 2013). Additionally, 
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research has shown that forced suppression or induction of ciliogenesis affects cell cycle 
progression, and it especially affects the transition from G0 to G1, supporting the idea 
that the presence or absence of primary cilia play a role in cell cycle progression (Goto, et 
al., 2013). 
Wnt Signaling Pathway 
Members of the wingless-type MMTV integration site family (wnt) are a group of 
secreted glycoproteins involved in tissue remodeling and homeostasis (Christodoulides, 
et al., 2009). In vivo, wnt signaling represses adipogenesis, as proven when disrupted 
wnt/β-catenin signaling induced adipogenesis (Figure-5). Additionally, wnt/β-catenin 
functioned during early development to prevent mesenchymal precursors from 
differentiating into adipocytes, further supporting a role for wnt signaling as an 
adipogenesis preventer (Christodoulides, et al., 2009). The wnt signaling pathway is 
composed of two individual pathways, the canonical and non-canonical wnt pathways. 
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Figure 5: The canonical wnt signaling pathway, planar cell polarity pathway, and non-canonical 
wnt signaling pathway showing proteins and target genes involved in wnt signaling (Abcam, 
2012). 
 
The canonical wnt signaling pathway regulates β-catenin by binding to frizzled 
(Frz) and lipoprotein-related-receptor-protein 5 or 6 (LRP 5/6) to inactivate the 
degradation complex that β-catenin forms (Christodoulides, et al., 2009). Although not 
yet fully understood, the non-canonical wnt signaling pathway works antagonistically to 
the canonical wnt pathway. It is believed that the non-canonical wnt signaling pathway 
might be regulated by ciliary function since it promotes adipogenesis (Christodoulides, et 
al., 2009). 
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PROJECT PURPOSE 
 
 The specific link between Bardet-Biedl Syndrome and the development of obesity 
and type II diabetes among BBS patients is not currently understood. However, it is 
widely believed that further research of BBS will reveal biochemical and developmental 
pathways instrumental in understanding the disease’s physical manifestations. This 
project examined how loss of the Bardet-Biedl Syndrome 2 gene affected the pancreas, 
glucose tolerance, and insulin sensitivity in order to gain a clearer understanding of how 
BBS causes obesity and type II diabetes. Only by understanding how these diseases 
develop can they one day be cured and prevented. 
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METHODS 
 
Ethics Statement 
All animals were housed in a viral-antibody-free facility and maintained 
according to both the Guide for the Care and Use of Laboratory Animals (Institute of 
Laboratory Animal Resources, 1996) and the University of Massachusetts Institutional 
Animal Care and Use Committee (IACUC). All animal-related research was approved by 
the University of Massachusetts IACUC. 
Cell Culture 
Rat insulinoma (INS1) cells were a gift from Dr. Fumihiko Urano at the 
University of Massachusetts Medical School. Insulinoma cells were grown in RPM1 
1640 media (Gibco, California) and supplemented with 10% fetal bovine serum (FBS), 
penicillin and streptomycin and concentrated sodium pyruvate A and BME. Cell cultures 
were kept at 37°C in an atmosphere of 5% CO2. The medium was changed every 3-4 
days and cells were regularly passaged twice a week. 
siRNA Transfection 
The siRNA used were from Ambion (California): siBBS2 5’ 
AAUAUCAUCAGUAUUCACCgt and scrambled (SCR, control) 5’ 
CAGUCGCGUUUGCGACUGG. Cells that siRNA transfection was performed on were 
plated in 6-well plates at 800,000 cells/well. Transfection with 10μL of siRNA was 
performed according to the manufacturer’s protocol using the lipofectamine 2000 reagent 
from Invitrogen. The optimal siRNA concentration was determined by using 
concentrations of 5μL and 10μL of siRNA. Since 10μL of siRNA after a 72 hour 
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transfection gave the most efficient knockdown, all subsequent experiments were 
performed using 10μL of siRNA for 72 hours. 
Western Blotting 
Insulinoma cells or pancreatic islets were prepared for western blot analysis by 
following the Pierce NE-PER Nuclear and Cytoplasmic Extraction Reagents lysate 
protocol using the cytosolic and nuclear lysate buffer from Pierce (Illinois). Denatured 
lysates were run on a Novex® 4-20% gradient gel with 1.5mm x 10 wells (Life 
Technologies, Massachusetts). Prior to loading, the concentration of lysates loaded into 
the gel were determined according to the Thermo Scientific Pierce 600nm Protein Assay 
from Pierce (Illinois). After the gels were run and transferred for 2 hours at 100mV to 
PVDF membranes, the membranes were blotted in 5% blotting-grade blocker nonfat dry 
milk from Bio Rad (Massachusetts) in Tris-Buffered Saline with 0.05% Tween 20 
(TBST) for 1 hour at room temperature. Primary antibodies were applied overnight in 5% 
milk. The primary antibodies used include BBS2 (Abcam, Massachusetts); Insulin 
(Sigma Aldrich, Massachusetts); Total β-catenin (Abcam, Massachusetts); P9 GSK3β 
(Cell Signaling Technology, Massachusetts); Cyclin D1 (Cell Signaling Technology, 
Massachusetts); LRP 5/6 (Novus Biologicals, Colorado); and Active β-catenin 
(Millipore, Massachusetts). Secondary antibodies were applied for 1 hour at room 
temperature in 5% milk TBST. The secondary antibodies used include goat anti-mouse or 
goat anti-rabbit HRP (Dako, California) conjugated at concentrations of 1:5,000 and 
1:3,000 respectively. The loading control used was actin from Millipore. The film was 
developed using HRP developing solution from GE Healthcare (Massachusetts), and 
luminescence was quantified using Adobe Photoshop software. Quantification was 
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performed by placing a box around the band and multiplying the average intensity by the 
area. This number was then calculated as a percent of the average intensity and area of 
the actin loading control. 
FACS/Cell Cycle Analysis 
Two wells from 72 hour, 10μL siRNA transfected insulinoma cells cultured at 
800,000 cells/well were combined. The cells were lifted with trypsin EDTA solution and 
made into a single cell suspension before the cells were pelleted and fixed drop-wise in 
500μL of -20°C 100% ethanol. SCR and siBBS2 cells were FACS sorted and cell cycle 
analysis was performed using MODFIT analysis by the University of Massachusetts Core 
Facility. 
Mouse Model 
The BBS2 mice used were a gift from Dr. Val C. Sheffield from Iowa, MD. 
Eight- to 15-week old mice of either sex were used. Mouse pancreatic islets were 
harvested according to (Parker, et al., 1995). A BBS2 genotyping test consisting of 4 
specific primers mixed equally was used to determine each mouse’s genotype. The 
~600bp band indicates wild type while the ~350bp band indicates a knock-out BBS2 
mouse. In Figure 6 below BBS2 mice genotyping is shown. 
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Figure 6: BBS2 Mice Genotyping 
 
Immunofluorescence 
Islets were fixed in 3.7% paraformaldehyde for 30 minutes at room temperature, 
and immunofluorescence was performed as described by (Gromley, et al., 2005). The 
primary antibodies included: BBS2 (1:100) (Abcam, Massachusetts); Insulin (1:250) 
(Sigma Aldrich, Massachusetts); Pericentrin (BD Biosceinces, California); and 
Acetylated Tubulin (1:100) (Abcam, Massachusetts). The secondary antibodies were 
Alexa-Fluor antibodies used at a concentration of 1:1,000; Cy-5 was used at a 
concentration of 1:100; and DAPI was used at a concentration of 1:10,000 (Sigma-
Aldrich). Coverslips were mounted with Prolong Antifade medium (Invitrogen). Images 
were taken using spinning-disk confocal microscopy on a Nikon Eclipse TE2000-E 
microscope, deconvolved, and analyzed using NIS Elements Analysis software. 
M 
Bbs2 mice genotyping 
(11.15.2012)
 44    45    46   47   48    49    50    
51  
  
Born 9/29/12 and 10/2/12  
50 
P born 12/6/11 
+/+ +/+ +/+ +/- +/- +/- +/- -/- +/- 
500bp 
100bp 
Mouse # 
WT Bbs2 product 
Bbs2 K/O product 
Genotype 
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Fluorescence intensity was determined by drawing a box around a specific area and the 
average intensity per pixel was recorded. 
Glucose Tolerance Test 
Blood glucose levels were determined by using an Accu-Check Active meter 
(Roche Diagnostics, Indiana) which tested a blood sample taken via a tail bleed. The day 
before the glucose tolerance test, a pre-fast (nonfasting) blood glucose and body weight 
were recorded. The animals were fasted overnight, and body weight and blood glucose 
readings were taken at timepoint 0. The insulin used was dissolved in 5mL of phosphate 
buffered saline (PBS) for every 1 gram of glucose, and mice were given an 
intraperitoneal injection of 2 grams of glucose for every kg of body weight. Blood 
glucose was recorded at 15, 30, 60, 90, and 120 minutes post glucose injection. 
Insulin Tolerance Test 
As described above, blood glucose levels were determined by using an Accu-
Check Active meter (Roche Diagnostics, Indiana). Prior to insulin tolerance testing (ITT) 
the animals were fasted for 5 hours and then the ITT was performed by challenging mice 
with 3 times their body weight of 0.20units/mL of humulin insulin diluted in sterile 
saline. Blood glucose levels were recorded at time points 0, 15, 30, 60, 90, and 120 
minutes post-injection. 
Perifusion 
A perifusion was performed on mouse islet cells that were isolated and plated 
overnight at 37°C. The following day the islets were counted and 25-50 islets were 
placed into an islet perifusion chamber using the islet perifusion instrument from 
National Instruments, Inc. (Florida). Islets were stimulated with a basal solution of 
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2.5mM glucose for 90 minutes at a rate of 90 reps/1 minute per rep/100μL/minute. The 
basal solution was removed and the cells were placed in the glucose stimulation solution 
of 20mM glucose for 35 minutes at 35 reps/1 minute per rep/100μL/minute, after which 
time the islets were again stimulated in basal solution for 15 minutes at a rate of 15 reps/1 
minute per rep/100μL/minute. The islets were then stimulated in the second glucose 
stimulation, a 20mM glucose solution, for 35 minutes at 35 reps/1 minute per 
rep/100μL/minute. After this time the islets were subjected to KCl stimulation in a 
solution of 20mM KCl for 10 minutes at 10 reps/1 minute per rep/100μL/minute. The 
solution was removed and replaced with the basal solution for 15 minutes at 15 reps/1 
minute per rep/100μL/minute. A total insulin extraction was then performed in 1mL of 
acidified ethanol extracted overnight at -20°C. 
Cilia Counts and Length Measurements 
Islets stained for pericentrin (centrosome marker), acetylated tubulin (cilia 
marker), and insulin were imaged using a 40X Plan/Apo lens on a Solamere Technology 
Group CSU10B Spinning Disk Confocal Microscope (Digital Light Microscopy Core, 
University of Massachusetts Medical School). A z-series of 50μm thick images were 
taken for each islet and used for cilia length measurements. The polyline length analysis 
feature of NIS Elements Analysis software was used to trace a line over the length of a 
cilium. The software then measured the length in pixels of the line that was drawn. Cilia 
lengths were recorded and converted to μm. Cilia were categorized by length as either 
short (< 8.00μm), medium (≥ 8.00μm and < 20.00μm), or long (≥ 20.00μm) so that 
statistical analysis of cilia lengths could be performed. 
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Statistics 
Statistical analysis was performed using Microsoft Excel. Differences were 
compared using two-tailed unimpaired t-tests. Values of p < 0.05 were considered 
statistically significant *, p < 0.01 was **, and p <0.001 was ***. 
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RESULTS 
 
The high frequency of obesity and type II diabetes among Bardet-Biedl Syndrome 
patients has brought attention to the syndrome as a way to discover biochemical and 
developmental pathways involved in the development of these diseases in BBS patients. 
Hopefully a clearer understanding of how obesity and type II diabetes arise in BBS 
patients will one day lead to the ability to prevent and cure these diseases. Since obesity 
and type II diabetes are known to be related to pancreatic function and insulin, this 
project looked at how knockout of the Bardet-Biedl Syndrome 2 gene affected the 
pancreatic islets’ morphology, glucose tolerance, and insulin sensitivity. BBS2 
knockdown resulted in low insulin levels in mice and glucose intolerance; however, the 
knockdowns had normal insulin sensitivity compared to the wild type. The primary cilia 
of BBS2 knockouts showed a distinct phenotypic difference where they were fewer, 
shorter, and less organized than in the wild type. In vitro knockdown of BBS2 led to 
lower insulin levels and downregulation of several canonical wnt signaling proteins, 
including Cyclin D1, a cell cycle progression marker. FACS cell cycle analysis of BBS2 
knockdown cultures showed disrupted cell cycle due to s-phase arrest. 
BBS2 Knockout Mice Are Born Small 
 The BBS2 knockout mouse model used was a gift from Dr. Val C. Sheffield. 
Mice were genotyped to determine if they were wild type (WT), BBS2 heterozygous 
(BBS2 Het), or BBS2 negative homozygotes (BBS2 KO). The BBS2 KOs were born 
abnormally small compared to their WT littermates (Figure 7).  The KO mice showed a 
distinct BBS2 phenotype while the heterozygotes didn’t appear to have any specific 
phenotype. 
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Figure 7: A BBS2 knockout mouse model. An image of the mice pups at a few days old, 
emphasizing the atypically small size of the BBS2 KO mice (left) compared to their WT litter mate 
(right). 
In vivo analysis was performed using mice from the BBS2 mouse model in Figure 
7. The glucose tolerance test (GTT), insulin tolerance test (ITT), and perifusion tests were 
all performed using an n of 2 animals. 
BBS2 Knockout Mice are Glucose Intolerant and Have Lower Insulin 
Levels 
 A glucose tolerance test was performed on WT, BBS2 Het, and BBS2 KO mice. 
Blood glucose levels were taken from the mice at various time points throughout the test, 
starting with a steady state, pre-fasting blood glucose reading. The mice were fasted 
overnight, after which time the time 0 blood glucose reading was taken. The mice were 
then injected with glucose, and blood glucose readings were taken at 15, 30, 60, 90, and 
120min after injection. 
 For the first 30 minutes a spike in blood glucose levels occurred as expected 
(Figure 8A). After this time, the body typically releases enough insulin to begin 
absorbing glucose into the surrounding tissue and a drop in blood sugar is seen. Blood 
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sugar levels are expected to continue to drop until they reach normal. The results of the 
GTT are shown along with plasma insulin readings taken pre-fasting and at time 0 min 
(Figure 8B). 
 
Figure 8: Glucose tolerance test (GTT) shows glucose intolerance in BS2 knockout mice. (A) In the GTT, BBS2 KO mice 
had elevated blood glucose levels compared to WT mice, and they remained elevated for the duration of the test. 
Persistent high blood glucose levels implies that the KO’s are either unable to produce enough insulin in response to 
the glucose or their cells are not properly responding to insulin. (B)  Insulin levels in the plasma were measured at two 
time points during the GTT. The Hets and KOs had lower nonfasting and time 0 insulin levels than the WT. 
 In the GTT, the BBS2 KO mice experienced a much higher and steeper spike in 
blood glucose levels. While the BBS2 KOs eventually showed decreased blood sugar 
levels, they were never able to come down as far or as fast as the WT or BBS2 Hets 
(Figure 8A). It was interesting to note that at the final time point, 120 minutes after the 
glucose injection, the BBS2 KO mice’s blood sugar levels started decreasing more slowly 
even though they were still significantly above 300 mg/dL. In addition to blood glucose 
levels, plasma insulin levels were measured pre-fast and at 0 min (Figure 8B) and show 
that both the BBS2 Hets and BBS2 KOs have much lower insulin levels than the WT. 
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 From this it is apparent that BBS2 KO mice are glucose intolerant since they are 
unable to remove glucose from the blood stream as efficiently or as quickly as the WT 
were able to. Typically glucose intolerant animals compensate for this by producing more 
insulin; however, the BBS2 KOs have unusually low insulin levels, so they are unable to 
compensate for their glucose intolerance. 
BBS2 Knockout Mice are Insulin Resistant 
 An insulin tolerance test (ITT) was performed on the mice to determine their 
insulin sensitivity and their ability to remove insulin from the blood stream (Figure 9). 
Mice were injected with insulin and their blood glucose levels were monitored 15, 30, 60, 
90, and 120 minutes after injection. 
 
Figure 9: BBS2 Hets and BBS2 KOs are insulin sensitive. This indicates that the results seen in the 
GTT are due to insulin resistance. 
  
The WT, BBS2 Hets, and BBS2 KOs all appeared to be equally insulin sensitive 
(Figure 9). As expected, all three experienced decreased blood sugar levels over the first 
half hour. Although the BBS2 Het and the BBS2 KO had higher blood sugar levels than 
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the WT, their blood sugar levels all decreased at the same rate, indicating equal insulin 
sensitivity. After the half hour timepoint, all animals’ blood sugar levels began 
increasing, indicating that they were able to absorb the excess insulin into the liver and 
the muscles to prevent hypoglycemia. At this point blood sugar levels rose to a normal 
level before they plateaued at a steady state. This was not seen among the BBS2 KO mice 
whose blood sugar levels did not plateau and instead rose to 250 mg/dL, indicating that 
BBS2 KOs are insulin resistant.  
Knockout of BBS2 Decreases Insulin Levels in Pancreatic Islets 
 In order to see how BBS2 knockout affects pancreatic insulin levels, sections of 
pancreas were mounted onto slides and stained for BBS2 and insulin (Figure 10A). An 
epifluorescent microscope was used to observe the pancreatic islets. BBS2 Hets (n = 40) 
were used as controls for the BBS2 KOs (n = 21). Quantitization was performed by 
measuring the intensity of the BBS2 or insulin staining (Figure 10B) using NIS Elements 
Analysis software. 
 31 
 
Figure 10: BBS2 knockout decreases insulin levels in pancreatic islets. (A) Pancreatic tissue from a heterozygous 
BBS2 mouse and a BBS2 KO mouse was stained for BBS2 (red), insulin (purple), and overlaid with DAPI (blue). 
Comparison shows lower BBS2 and insulin levels in the KO mouse compared to the heterozygote. (B) BBS2 and insulin 
intensities were compared between the heterozygote and BBS2 KO, and lower levels of BBS2 and insulin in pancreatic 
islets was observed. 
 The staining showed that BBS2 (Figure 10A, top) is a cytosolic protein expressed 
in the pancreas, and while it is present in islets, BBS2 is not exclusively expressed there 
as it is also expressed in insulin negative cells. Using NIS Elements software, the 
intensity of the BBS2 staining was quantitized, showing significantly reduced levels of 
BBS2 (Figure 10B, top). Similarly, insulin levels were determined, and analysis showed 
significant knockdown of insulin in BBS2 KO islets compared to the controls (Figure 
10B, bottom). From these stains it is apparent that BBS2 knockout leads to decreased 
insulin levels in pancreatic islets. 
BBS2 Knockout Shows Abrogated Insulin Secretion 
Since insulin levels are difficult to determine in vivo due to compensatory 
mechanisms to keep the glucose level in check, pancreatic islets from WT, BBS2 Hets, 
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and BBS2 KOs were isolated and cultured overnight so that insulin secretion in the islets 
could be determined in vitro. This was accomplished by performing a perifusion test 
(Figure 11). Plated islets were treated with various stimulatory solutions and the amount 
of insulin secreted by the islets was measured.  
First the islets were treated with a non-stimulatory basal solution that was 2.5mM 
glucose; they were then stimulated with a 20mM glucose solution. Next the non-
stimulatory 2.5mM glucose solution was used to returned the cells to normal insulin 
secretion, and after this they were again stimulated with a 20mM glucose solution. 
Finally, the islets were then treated with a 20mM KCl solution which depolarized the 
islets’ cell membranes, opening Ca+ channels, and allowing the islets to excrete all 
releasable insulin, about 1-2% of the total insulin contained in the islet. After this was 
done, the islets were again treated with 2.5mM glucose solution. Acidified ethanol was 
then used to lyse the islets’ cell membranes and all of the insulin contained in the islets 
was released and could be measured. 
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Figure 11: Despite low overall levels of insulin, BBS2 heterozygotes hypersecrete insulin in response to glucose 
stimulation while BBS2 KOs hyposecrete insulin. (A) Pancreatic islets were isolated and in vitro insulin levels were 
tested. Islets were stimulated in a series of solutions: 2.5mM glucose basal solution, 20mM stimulatory solution, and 
20mM KCl. The 20mM glucose stimulation shows how islets respond to glucose. The KCl stimulation depolarizes the 
cell membrane, and the total releasable insulin in the islets was measured. BBS2 Hets hypersecrete insulin in 
response to glucose stimulation while BBS2 KOs hyposecrete insulin. Both Hets and KOs contain lower levels of 
releasable insulin than the WT. (B) After the perifusion was completed, acidified ethanol was used to lyse the islets so 
the total amount of insulin remaining in the islets could be determined. WT islets contained significantly more insulin 
than both the Hets and KOs, which have low total insulin levels. 
 When the islets were stimulated with the 20mM glucose solution, the BBS2 Hets 
responded by hypersecreting insulin but the BBS2 KOs hyposecreted insulin. This 
unexpected result shows that while knockout of BBS2 leads to insulin hyposecretion, 
knockout of just one copy of the BBS2 gene results in insulin hypersecretion in response 
to glucose stimulation. Despite the Hets ability to hypersecrete insulin, both they and the 
KOs contained much lower levels of releasable insulin than the WT islets. Additionally, 
the total insulin levels measured in the WT islets were 101.18 ng/mL and 92.87 ng/mL. 
These levels are higher than the total insulin levels in the BBS2 Hets (32.38 ng/mL and 
54.38 ng/mL) and the BBS2 KOs (48.99 ng/mL and 75.59 ng/mL). 
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Primary Cilia in BBS2 Knockouts are Shorter and Fewer 
Cross sections of pancreatic tissue from WT and BBS2 KO mice were collected 
and mounted on slides. Immunofluorescence was used to probe for pericentrin (Figure 
12A & H), acetylated tubulin (Figure 12B & I), and insulin. Figure 12 shows WT and 
KO islets stained for various proteins. NIS Elements Analysis software was used to trace 
a line over the length of the cilia; the computer then determined how long the cilia were 
in pixels, and the length was converted to μm. Images were taken in a z-series to count 
the cilia, but are presented as maximum intensities across the z-series.  
 
Figure 12: BBS2 mutation affects primary cilia morphology in pancreatic islet cells. Images of WT pancreatic islets 
(left) compared to KO islets (right) were taken using confocal microscopy to observe primary cilia presence and 
morphology. Staining shows pericentrin (green) and Dapi (A & H); acetylated tubulin (red) and Dapi (B & I); and 
pericentrin, acetylated tubulin, insulin (purple) and Dapi (C & J). A z-series of images were taken, and a maximum 
expose across the z-series was examined for pericentrin and acetylated tubulin (D & F). Pericentrin and acetylated 
tubulin staining were used to determine primary cilia lengths (E & G). Inlays show a magnified image of a primary 
cilium for both maximum intensity and cilia lengths. WT images (A-E) appear more organized, and they have a higher 
density of centrosomes and cilia compared to the BBS2 KOs (F-J).  
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 Figure 12 shows overlays of pericentrin and Dapi (Panels A & H); acetylated 
tubulin and Dapi (Panels B & I); pericentrin, acetylated tubulin, insulin, and Dapi (Panels 
C & J); a maximum intensity exposure of pericentrin and acetylated tubulin (Panels D & 
F); and pericentrin and acetylated tubulin with cilia tracings (Panels E & G). Inlays show 
a single cilia attached to a centrosome (Panels D – G). The WT and BBS2 KO islet 
images show a distinct phenotypic difference between the two. The WT primary cilia 
appear more numerous and organized. The BBS2 KO islets appear to have few, poorly 
organized cilia that aggregated into indistinct clusters. Although the BBS2 KO cilia 
appeared to be shorter than the WT, cilia length measurements were collected and 
compared in Figure 13. 
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Figure 13: Primary cilia in pancreatic islets of BBS2 KOs are shorter than in the WT. (A) Cilia traced in pancreatic 
islets were measured and graphed as histograms. (B & C) Primary cilia lengths were categorized as either short (< 8.00 
μm), medium (8.00 μm  - 20.00 μm), or long (> 20.01μm). The percent of total cilia in each category was determined 
in WT and BBS2 KOs, and is represented in pie charts (inlaid). Cilia lengths in WT islets were 64.3% medium, 30.7% 
short, and 5.0% long (B). BBS2 KO islets contained 61.7% short cilia, 34.1% medium, and 4.2% long (C). 
 
 The histograms of cilia lengths show the number of cilia counted in increments of 
2μm. There is clearly a distinct phenotypic difference between WT  (n = 599) and BBS2 
KO (n = 818) cilia. A comparison of the lengths (Figure 13A) shows that while the WT 
cilia tend to be medium length with some short and long cilia, the BBS2 KO cilia were 
generally short with some medium and long cilia. Inlaid in Figure 13B & C are pie charts 
showing the percent of total cilia counted that belonged to WT and BBS2 KO islets 
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respectively. The WT had 30.7% short cilia, 64.3% medium cilia, and 5.0% long cilia. 
The BBS2 KO had 61.7% short cilia, 34.1% medium cilia, and 4.2% long cilia. It is 
surprising that despite the marked difference in the percent of short vs. medium cilia 
between the WT and BBS2 KO, they had similar percentages of long cilia. 
BBS2 Knockdown Results in Decreased Insulin Levels 
BBS2 was knocked down in vitro using a rat insulinoma cell line. Lipofectamine 
was used to transfect the cells with 10μL of siRNA against BBS2 or scrambled (SCR) 
siRNA. Seventy-two hours after transfection, the cells were lysed and cytosolic extract 
was collected. Western blot analysis was performed on the denatured lysates and insulin 
was probed for (Figure 14, top); actin was used as a loading control. Quantitization was 
performed on the western by drawing a perimeter around the band that was presented. 
The average intensity of the band was multiplied by the area of the band and normalized 
to actin (Figure 14, bottom). Statistical analysis was performed on insulin intensity 
levels between the SCR and siBBS2 lysates. 
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Figure 14: Lower insulin levels induced by BBS2 knockdown. Knockdown of BBS2 was 
accomplished in vitro using siRNA against BBS2; SCR siRNA was used as a control. A western blot 
analysis was performed to compare insulin levels between the SCR and siBBS2 and shows 
significantly lower levels of insulin in siBBS2 cells compared to the control. 
 
 BBS2 knockdown resulted in lower insulin levels among insulinoma cells 
compared to those transfected with SCR siRNA. Although insulin levels were visually 
lower in the siBBS2 cells, quantitization showed significant reduction of insulin between 
the siBBS2 and control.  
Downregulation of wnt Signaling Genes in BBS2 Knockdown 
 BBS2 knockdown was most completely achieved by transfecting cells with 
siRNA and collecting lysates 72 hours after transfection. One western, however, was run 
with 5μL and 10μL of siBBS2 to determine which concentration was more effective at 
knocking down BBS2. Figure 15 shows that BBS2 knockdown was most effective when 
10μL of siBBS2 were used, so all remaining siRNA transfections were performed with 
10μL of siBBS2. 
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In addition to observing how BBS2 knockdown affected insulin levels, various 
genes involved in the canonical wnt signaling pathway were probed for (Figure 15). 
BBS2 was probed for to ensure that siRNA knockdown of BBS2 was successful. 
 
Figure 15: BBS2 knockdown results in downregulation of canonical wnt signaling proteins. 
Western blot analysis of cytosolic lysates from 72 hour siRNA knockdowns were probed for 
various proteins involved in the canonical wnt signaling pathway. BBS2, total β-catenin, P9 GSK3β, 
Cyclin D1, LRP 5/6, and active β-catenin were all downregulated in BBS2 knockdown. 
 
 The canonical wnt signaling pathway is involved in adipogenesis repression. Due 
to the high prevalence of obesity and diabetes mellitus among BBS patients, it was 
expected that canonical wnt signaling would be disrupted as a result of BBS2 
knockdown. Total β-catenin is a cytosolic protein which forms a degradation complex if 
it isn’t activated by the wnt signaling pathway. BBS2 knockdown led to slightly lower 
levels of total β-catenin; however, while there was a slight difference it does not appear to 
be significant. Phospho-9-GSK3β (P9GSK3β) is an inhibitory phosphorylation of GSK3β 
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which leads to inactivation of this constitutively active protein and turns on wnt signaling. 
This leads to accumulation of β-catenin and translocation to the nucleus, where β-catenin 
stimulates production of proteins necessary for cell cycle progression. Western blot 
analysis showed slight downregulation of P9GSK3β with BBS2 indicating 
downregulation of wnt signaling in BBS2 KO. Cyclin D1 was also probed for on the 
western blot because it is a target gene of the wnt signaling pathway, and it is only 
transcribed if canonical wnt signaling occurs. Cyclin D1 levels appeared to be much less 
on the western blot, indicating that canonical wnt signaling is being disrupted. 
At the beginning of the canonical wnt signaling pathway, wnt activates receptor 
LRP 5/6. In vitro knockdown of BBS2 showed significantly reduced levels of LRP 5/6, 
indicating that BBS2 affects the wnt signaling pathway early on. Active β-catenin was 
also downregulated in BBS2 knockdown. Active β-catenin is a nuclear protein involved 
in the complex that allows transcription of wnt target genes to occur. Analysis showed 
that active β-catenin levels were significantly lower with BBS2 knockdown. Significantly 
lower levels of LRP 5/6 and active β-catenin combined with the apparently lower levels 
of total β-catenin, P9 GSK3β, and Cyclin D1 indicate that BBS2 knockdown leads to 
downregulation of the canonical wnt signaling pathway. 
Depletion of BBS2 in β–Cells Results in S-Phase Arrest 
 In addition to being a target gene of the canonical wnt signaling pathway, Cyclin 
D1 is a cell cycle progression marker, so the decreased levels of Cyclin D1 seen with 
BBSS2 knockdown indicated cell cycle arrest. To determine whether or not cell cycle 
arrest occurred with BBS2 knockdown a FACS analysis was performed to determine 
which stage of the cell cycle siBBS2 transfected cells were in (Figure 16). 
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Figure 16: BBS2 knockdown results in s-phase arrest of β-cells. FACS cell cycle analysis was 
performed on BBS2 knockdown cells. Significantly more cells transfected with SCR were found to 
be in the G0/G1 phases of the cell cycle. Compared to the control, siBBS2 cells spent significantly 
more time in the s-phase of the cell cycle. The high percent of siBBS2 cells in the s-phase imply 
that BBS2 knockdown causes s-phase cell cycle arrest. 
 
 The FACS analysis of siRNA transfected cells showed that most SCR cells were 
in either the G0 or G1 phase of the growth cycle. Significantly fewer siBBS2 cells were 
found to be in the G0/G1 phases; instead, the siBBS2 cells were found to be in the s-
phase of the cell cycle. There was no statistical difference in the percent of cells found in 
the G2 or M. The large difference in which stage of the cell cycle siBBS2 cells were in 
compared to the control indicates that cell cycle arrest occurs, and that BBS2 knockdown 
causes cells to become stuck in the s-phase. 
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DISCUSSION 
 
Main Conclusions 
The complications associated with Bardet-Biedl Syndrome indicate how 
important primary cilia are in the human body. The high frequency of obesity and type II 
diabetes among BBS patients has recently drawn attention to the syndrome as a potential 
way to better understand developmental and signaling pathways involved in the onset of 
these diseases. This project explored how the loss of BBS2 gene function affected 
glucose homeostasis and the length of primary cilia in pancreatic islet cells. It also 
examined the effect of BBS2 knockdown on the canonical wnt signaling pathway, known 
to be involved in adipogenesis repression, and cell cycle progression. 
BBS2 knockout mice showed glucose intolerance but normal insulin resistance. 
The glucose tolerance test showed glucose intolerance, and plasma insulin level 
measurements indicated that BBS2 knockout animals have low blood insulin levels 
compared to the wild type. The insulin tolerance test showed similar insulin sensitivities 
between the BBS2 knockouts and the wild type; however, the knockouts were unable to 
stabilize their blood glucose levels in response to high insulin levels.  
Morphological stains of pancreatic tissue from BBS2 knockouts had significantly 
lower insulin levels in the islets, supporting the potential for BBS2 knockouts to be 
insulin deficient. The perifusion results agreed with the idea of low insulin levels in 
BBS2 knockouts, who throughout the perifusion hyposecreted insulin in response to 
glucose stimulation and had lower total insulin levels. While typically glucose intolerance 
is compensated for with increased insulin levels, the BBS2 knockouts did not appear to 
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have this ability, indicating that their ability to produce insulin could be compromised in 
complete BBS2 KO since the Hets were still able to hypersecrete insulin. 
Pancreatic islets from BBS2 knockout mice were stained for pericentrin, a 
centrosome marker, and acetylated tubulin to show the presence or absence of primary 
cilia in the islets. Islets from BBS2 knockouts clearly had fewer, shorter, and less 
organized cilia than the wild type. The wild type cilia are clearly discernible in Figure 
12E. However, the BBS2 knockout cilia in Figure 12G were disorganized and 
aggregated, making them indiscernible in some areas. Although the wild type contained 
predominantly medium length cilia (64.3%) and fewer short cilia (30.7%), the BBS2 
knockouts contained mostly short cilia (61.7%) and fewer medium length cilia (34.1%). 
This distinct BBS2 knockout phenotype of short, atypical cilia fits with the literature that 
BBS is a ciliopathy so patients have cilia that are either structurally impaired. 
Knockdown of BBS2 was accomplished in vitro using rat insulinoma cells 
transfected with siRNA against BBS2. The in vitro knockdown confirmed lower insulin 
levels among BBS2 knockdown compared to the control, and supporting the in vivo 
findings that loss of BBS2 results in compromised insulin levels. In addition to 
determining how insulin levels were affected by BBS2 knockdown, various proteins 
involved in the canonical wnt signaling pathway were observed in the same way. The role 
of the canonical wnt signaling pathway in adipogenesis repression indicated it as a 
signaling pathway with the potential to play a role in the presence of obesity among BBS 
patients. 
This project was able to show significant downregulation of wnt signaling 
proteins LRP 5/6 and active β-catenin and their target Cyclin D1 due to BBS2 
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knockdown. There appeared to be downregulation of two other wnt proteins and a wnt 
signaling target gene as well; total β-catenin, phosphor-9 GSK3β, and Cyclin D1 were all 
observed in lower levels in BBS2 knockdown compared to the control. Cyclin D1, a 
target gene of the canonical wnt signaling pathway, is a cell cycle progression marker. 
When a FACS cell cycle analysis was performed on BBS2 knockdown cells, it was 
discovered that knockdown of BBS2 results in s-phase arrest.  
This finding fits with the abnormally few cilia seen in the BBS2 knockout islets 
compared to the wild type. When cells enter the cell cycle, they retract their primary cilia. 
Accordingly, if a higher number of BBS2 knockout cells are arrested in the s-phase of the 
cell cycle, they would not have cilia, giving a plausible explanation for the low number of 
cilia seen in the islet stains. 
Research Complications 
 The most challenging problem encountered throughout this project was the small 
number of BBS2 knockout mice available for testing. Although BBS2 knockout mice 
were born, their small body sizes and poor health often lead to death before they were old 
enough to be used in experiments such as the glucose tolerance test, insulin tolerance test, 
and perifusion. All of these experiments were n = 2, and they should be repeated with a 
larger population. Despite the small population used in these experiments, the fact that all 
of the tests performed pointed to the conclusion that loss of BBS2 leads to glucose 
intolerance and low levels of insulin indicates that the results describe a BBS phenotype. 
Future Research 
 In addition to performing the glucose tolerance test, insulin tolerance test, and 
perifusion with more mice, a better understanding of the link between BBS2 and obesity 
and diabetes would come from performing a variety of other experiments. The idea that 
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BBS2 knockdown causes cell cycle arrest should be verified with several other cell cycle 
progression markers, including a BrdU assay, KI67 staining, a tunnel assay, and a 
phosphohistone H3 assay. BrdU will allow the fate of the cell to be determined, 
specifically if cells are arrested in the s-phase. If a Tunel assay is used as a follow-up, it 
will be possible to determine if the arrested cells eventually undergo apoptosis or if they 
are able to eventually exit the cell cycle. 
 Somatostatin receptor 3 (SSTR3) is a protein involved in the secretion of 
hormones such as insulin. Since low plasma insulin levels were seen in this project, it 
would be interesting to discover if SSTR3 is localized to the cilia of pancreatic islets. The 
presence of SSTR3 on the primary cilia could influence the ability of the islets to secrete 
insulin, and thus explain the insulin hyposecretion seen in the perifusion performed on 
the BBS2 knockout islets. 
 The downregulation of several canonical wnt signaling proteins was observed 
throughout this project, and it would be interesting to discover whether or not other 
canonical wnt signaling genes were downregulated as well. This could easily be 
performed in vitro, and would confirm or deny the idea that BBS2 plays a role in 
canonical wnt signaling. While the canonical wnt signaling pathway represses 
adipogenesis, the non-canonical wnt signaling pathway is involved in adipogenesis. The 
two pathways are antagonistic, so non-canonical wnt signaling genes should be 
examined, and upregulation of these genes would be expected. 
  
 46 
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